Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

7.90

+0.52 (7.05%)

At close: Jun 27, 2025, 4:00 PM

7.50

-0.40 (-5.06%)

After-hours: Jun 27, 2025, 6:21 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $14.32 million as of June 27, 2025. Its market cap has decreased by -87.83% in one year.

Market Cap

14.32M

Enterprise Value

884.28K

1-Year Change

-87.83%

Ranking

#5036

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $14.32M, an increase of 90.87%. That is a compound annual growth rate of 3.35%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	11.30M	-8.13%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	698.51B
Johnson & Johnson	366.18B
AbbVie	327.76B
Novo Nordisk	313.40B
UnitedHealth Group	277.24B
Abbott Laboratories	240.24B
Novartis AG	232.39B
AstraZeneca	218.32B

Market Cap Rankings